Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Chlorphenesin is a mild eye irritant and it is classified as skin irritant on precautionary manner.

Key value for chemical safety assessment

Skin irritation / corrosion

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (irritating)

Eye irritation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Skin irritation/corrosion

Chlorphenesin was tested in 2014 for its skin irritation potential with an in vitro test according to OECD TG 439 EPISKINTM reconstructed human epidermis model. No classification for skin irritation should be required based on this in vitro test. Due to minor concern on epidemiological data, classification H315 (skin irr., cat.2) is assigned as precautionary measure.

 

Eye irritation

Two in vitro studies are available regarding eye irritation of Chlorphenesin:

- OECD TG 437- BCOP method: IVIS test item: 25.2. 

- OECD TG 492- EpiOcularTM Eye Irritation Test: Viability measured after application of test item: 2.40%

Chlorphenesin is classiifed H319 (eye irritant category 2). The eye irritation potential (but not serious eye damage concern) is confirmed also by an in vivo study performed before the implementation of the Regulation (EC n.1223/2009).

Justification for classification or non-classification

Chlorphenesin is classified H319 (eye irr. cat.2) and as precautionary manner H315 (skin irr. cat.2) according to the CLP Regulation (EC.n.1272/2008). For justification see the results of available studies.